ES2191106T3 - Uso de ondansetron en la fabricacion de un medicamento para el tratamiento del temblor. - Google Patents
Uso de ondansetron en la fabricacion de un medicamento para el tratamiento del temblor.Info
- Publication number
- ES2191106T3 ES2191106T3 ES96929991T ES96929991T ES2191106T3 ES 2191106 T3 ES2191106 T3 ES 2191106T3 ES 96929991 T ES96929991 T ES 96929991T ES 96929991 T ES96929991 T ES 96929991T ES 2191106 T3 ES2191106 T3 ES 2191106T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- temblor
- ondansetron
- manufacture
- medicinal product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 229960005343 ondansetron Drugs 0.000 title 1
- 102000035037 5-HT3 receptors Human genes 0.000 abstract 1
- 108091005477 5-HT3 receptors Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA INVENCION PROPORCIONA EL USO DE UN ANTAGONISTA DE LOS RECEPTORES 5-HT 3 O UN DERIVADO FARMACEUTICAMENTE ACEPTABLE DE ESTE PARA USO EN EL TRATAMIENTO DE LA DISCINESIA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9519021.1A GB9519021D0 (en) | 1995-09-18 | 1995-09-18 | Medicaments |
GBGB9519029.4A GB9519029D0 (en) | 1995-09-18 | 1995-09-18 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2191106T3 true ES2191106T3 (es) | 2003-09-01 |
Family
ID=26307778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96929991T Expired - Lifetime ES2191106T3 (es) | 1995-09-18 | 1996-09-16 | Uso de ondansetron en la fabricacion de un medicamento para el tratamiento del temblor. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0851756B1 (es) |
JP (1) | JP3411292B2 (es) |
KR (1) | KR19990045728A (es) |
CN (1) | CN1201390A (es) |
AT (1) | ATE230988T1 (es) |
AU (1) | AU6921196A (es) |
BR (1) | BR9610526A (es) |
CA (1) | CA2231887A1 (es) |
CZ (1) | CZ82698A3 (es) |
DE (1) | DE69625819T2 (es) |
EA (1) | EA199800204A1 (es) |
ES (1) | ES2191106T3 (es) |
HU (1) | HUP9900606A2 (es) |
IL (1) | IL123536A0 (es) |
IS (1) | IS4686A (es) |
NO (1) | NO981188L (es) |
PL (1) | PL325560A1 (es) |
TR (1) | TR199800488T1 (es) |
WO (1) | WO1997010823A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003237657A1 (en) * | 2002-05-24 | 2003-12-12 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using "setrones" |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8808433D0 (en) * | 1988-04-11 | 1988-05-11 | Merck Sharp & Dohme | Therapeutic agents |
US5140034A (en) * | 1989-03-14 | 1992-08-18 | Merck Sharp & Dohme Ltd. | Five-membered ring systems with bonded imidazolyl ring substituents |
ATE137501T1 (de) * | 1989-07-03 | 1996-05-15 | Yoshitomi Pharmaceutical | Benzazin-verbindungen und deren pharmazeutische verwendungen |
FR2674853B1 (fr) * | 1991-04-03 | 1995-01-20 | Synthelabo | Derives de piperidinylguanidine, leur preparation et leur application en therapeutique. |
FR2693194B1 (fr) * | 1992-07-03 | 1994-09-23 | Synthelabo | Dérivés d'alcanecarboxamide, leur préparation et leur application thérapeutique. |
FR2696177B1 (fr) * | 1992-09-28 | 1995-05-12 | Synthelabo | Dérivés de pipéridine, leur préparation et leur application en thérapeutique. |
FR2710915B1 (fr) * | 1993-10-04 | 1995-11-24 | Synthelabo | Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique. |
FR2731708B1 (fr) * | 1995-03-13 | 1997-04-30 | Synthelabo | Derives de piperidine, leur procede de preparation et leur application en therapeutique |
-
1996
- 1996-09-16 EP EP96929991A patent/EP0851756B1/en not_active Expired - Lifetime
- 1996-09-16 PL PL96325560A patent/PL325560A1/xx unknown
- 1996-09-16 KR KR1019980701969A patent/KR19990045728A/ko not_active Application Discontinuation
- 1996-09-16 AU AU69211/96A patent/AU6921196A/en not_active Abandoned
- 1996-09-16 TR TR1998/00488T patent/TR199800488T1/xx unknown
- 1996-09-16 BR BR9610526A patent/BR9610526A/pt not_active Application Discontinuation
- 1996-09-16 AT AT96929991T patent/ATE230988T1/de not_active IP Right Cessation
- 1996-09-16 CN CN96198141A patent/CN1201390A/zh active Pending
- 1996-09-16 CZ CZ98826A patent/CZ82698A3/cs unknown
- 1996-09-16 ES ES96929991T patent/ES2191106T3/es not_active Expired - Lifetime
- 1996-09-16 CA CA002231887A patent/CA2231887A1/en not_active Abandoned
- 1996-09-16 DE DE69625819T patent/DE69625819T2/de not_active Expired - Fee Related
- 1996-09-16 HU HU9900606A patent/HUP9900606A2/hu unknown
- 1996-09-16 IL IL12353696A patent/IL123536A0/xx unknown
- 1996-09-16 JP JP51226097A patent/JP3411292B2/ja not_active Expired - Fee Related
- 1996-09-16 EA EA199800204A patent/EA199800204A1/ru unknown
- 1996-09-16 WO PCT/CA1996/000616 patent/WO1997010823A1/en active IP Right Grant
-
1998
- 1998-03-09 IS IS4686A patent/IS4686A/is unknown
- 1998-03-17 NO NO981188A patent/NO981188L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JP3411292B2 (ja) | 2003-05-26 |
MX9802001A (es) | 1998-10-31 |
CN1201390A (zh) | 1998-12-09 |
KR19990045728A (ko) | 1999-06-25 |
WO1997010823A1 (en) | 1997-03-27 |
EP0851756A1 (en) | 1998-07-08 |
DE69625819D1 (de) | 2003-02-20 |
IS4686A (is) | 1998-03-09 |
EA199800204A1 (ru) | 1998-10-29 |
DE69625819T2 (de) | 2003-11-06 |
TR199800488T1 (xx) | 1998-05-21 |
HUP9900606A2 (hu) | 2000-03-28 |
AU6921196A (en) | 1997-04-09 |
NO981188D0 (no) | 1998-03-17 |
PL325560A1 (en) | 1998-08-03 |
NO981188L (no) | 1998-05-13 |
JPH10511986A (ja) | 1998-11-17 |
EP0851756B1 (en) | 2003-01-15 |
BR9610526A (pt) | 1999-07-06 |
ATE230988T1 (de) | 2003-02-15 |
CZ82698A3 (cs) | 1998-08-12 |
CA2231887A1 (en) | 1997-03-27 |
IL123536A0 (en) | 1998-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2091877T3 (es) | Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia. | |
CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
CO4930259A1 (es) | Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen | |
ES2156287T3 (es) | Derivados de difenilmetilen piperidina. | |
DE69812159D1 (de) | Derivate des adamantan | |
SE9704544D0 (sv) | Novel compounds | |
SV1998000029A (es) | Compuestos de pirazina ref. pg3186 | |
ES2145774T3 (es) | Derivados de adenosina que tienen actividad agonista en a2. | |
ES2122764T3 (es) | Inhibidor de la proteina quinasa c. | |
NO20000572D0 (no) | Indolderivater som MCP-1 reseptor antagonister | |
AR025883A1 (es) | Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos | |
AR008878A1 (es) | Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento. | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
EP0781561A4 (en) | NEW MEDICAL USE OF A 5HT 3 ANTAGONIST? | |
PA8527401A1 (es) | 7-oxo-piridopirimidinas (ii) | |
BRPI0107493B8 (pt) | substâncias para uso no tratamento de psoríase | |
AR035006A1 (es) | Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento. | |
AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
ES2167721T3 (es) | Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica. | |
ES2191106T3 (es) | Uso de ondansetron en la fabricacion de un medicamento para el tratamiento del temblor. | |
ES2191908T3 (es) | 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido. | |
AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
UY26224A1 (es) | Complejo farmaceutico ley 17164 art. 127 | |
ES2170402T3 (es) | Derivados de benzo(g)quinolina. |